Asensus Surgical

Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System features a machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Durham, NC.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Asensus Surgical reports Q1 loss but eyes stability through acquisition

Asensus Surgical's Q1 2024 performance showed a significant net loss, but the potential acquisition by KARL STORZ offers financial stability. The company aims to sustain operations into Q3 2024 and beyond with available cash and additional financing. Ongoing initiatives focus on advancing surgical systems and expanding global programs.

Asensus Surgical reports Q2 losses, merger vote adjourned

Asensus Surgical faces financial struggles with a significant net loss and liquidity concerns.
The proposed merger with Karl Storz offers a potential strategic advantage but hinges on stockholder approval.
Addressing operational inefficiencies and investor engagement are critical for long-term success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Asensus Surgical is a digital interface between the surgeon and patient to improve minimally invasive surgery through digital laparoscopy. They enable capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seek to address the current clinical, cognitive, and economic shortcomings in surgery.

LM Funding America

Mobilicom 

Sorrento Therapeutics Inc

Penny stocks with big news in February 2023. Are they the best to buy now?

Best Penny Stocks To Buy Now? 4 With Big News In February

The Companies intend to collaborate on developing next-generation instrumentation and KARL STORZ intends to sell Asensus' Intelligent Surgical Unit (ISU) as a standalone device The Companies intend to collaborate on developing next-generation instrumentation and KARL STORZ intends to sell Asensus' Intelligent Surgical Unit (ISU) as a standalone device

Asensus and KARL STORZ to Market the Intelligent Surgical Unit and Co-Develop New Vision and Instrument Platforms

RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, today announced a multi-year collaboration with Google Cloud to integrate Google Cloud's secure cloud data architecture and machine learning (ML) technologies to further expand the capabilities of the Asensus Surgical's Performance-Guided Surgery™ (PGS) framework enabled through the Intelligent Surgical Unit ™ (ISU™).

Asensus Surgical Announces Machine Learning and Cloud Infrastructure Collaboration with Google Cloud to Advance Performance-Guided Surgery

RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, today announced that President and CEO Anthony Fernando will be joined by other leaders of the Company to ring the opening bell of the New York Stock Exchange on February 21, 2023. On the same day, the Company is hosting an Investor Day.

Asensus Surgical to Ring New York Stock Exchange Opening Bell on February 21, 2023

RESEARCH TRIANGLE PARK, N.C., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the Company will host an Investor Day on Tuesday, February 21, 2023 in New York City.

Asensus Surgical to Host Investor Day on February 21, 2023

Avaya Holdings

Cenntro Inc

Novo Integrated Sciences, Inc.

PolyPid

Troika Media Group

Lightning eMotors, Inc

Penny stocks under $1 to watch right now. The post 7 Top Penny Stocks Under $1 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

7 Top Penny Stocks Under $1 To Watch Before Next Week

Expanded Intelligent Surgical Unit™ (ISU™) capabilities include 3D measurement, digital tagging, image enhancement, and enhanced camera control, for our European customers Expanded Intelligent Surgical Unit™ (ISU™) capabilities include 3D measurement, digital tagging, image enhancement, and enhanced camera control, for our European customers

Asensus Surgical Receives CE Mark for Expanded Machine Vision Capabilities

RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2022 year-end corporate update.

Asensus Surgical Provides Preliminary 2022 Year-End Corporate Update

RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the management team will participate and present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 12:00 PM PST.

Asensus Surgical, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference

First hospital to install a second Senhance Surgical System First hospital to install a second Senhance Surgical System

Asensus Announces Kitakyushu General Hospital in Japan to Initiate Second Senhance System

Continued expansion of the Senhance Program in the region Continued expansion of the Senhance Program in the region

Asensus Announces Senhance Program Initiation at Kashiwa Kosei General Hospital of Japan

10th hospital in Germany to initiate a Senhance System 10th hospital in Germany to initiate a Senhance System

Asensus Announces Senhance System Placement at GPR Klinikum Rüsselsheim of Germany

Oncology focused hospital to initiate Senhance System program Oncology focused hospital to initiate Senhance System program

Asensus Announces Additional Senhance Surgical System Sale

RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference in Miami, Florida. The Company's panel presentation, Launching on Society: Early Commercial MedTech Names with New Technologies in Large Patient Populations, will take place on Thursday, December 8, 2022 at 11:00 AM Eastern Time. A Key Opinion Leader Luncheon presentation, A Discussion on Robotic Devices in Surgery, will also be held on Thursday, December 8, 2022 at 12:15 PM Eastern Time, featuring Dr. Steven McCarus,Chief of Gynecology Surgery at AdventHealth Winter Park, Florida.

Asensus Surgical to Participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference

Asensus Surgical, Inc. (NYSE:ASXC ) Q3 2022 Results Conference Call November 10, 2022 4:30 PM ET Company Participants Mark Klausner - Investor Relations Anthony Fernando - President and Chief Executive Officer Shameze Rampertab - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Jennifer Sadeghi - H.C. Wainwright Operator Good day and welcome to the Asensus Surgical Incorporated 2022 Third Quarter Financial and Operating Conference Call.

Asensus Surgical, Inc. (ASXC) Q3 2022 Earnings Call Transcript

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 0% and 25.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Asensus Surgical (ASXC) Reports Q3 Loss, Misses Revenue Estimates

RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the third quarter 2022.

Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2022

RESEARCH TRIANGLE PARK, N.C., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the Dr. von Hauner Children's Hospital at the Ludwig Maximilians University Munich (“LMU”), located in Munich, Germany, has entered into an agreement to lease and utilize a Senhance® Surgical System.

Asensus Surgical Announces Ludwig Maximilians University in Germany to Initiate Senhance Pediatric Surgery Program

RESEARCH TRIANGLE PARK, N.C., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2022 third quarter financial and operating results after the market closes on Thursday, November 10, 2022. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast.

Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 10, 2022

Presentation on Tuesday, October 25 at 8:30 am PTResearch Triangle Park, North Carolina--(Newsfile Corp. - October 18, 2022) - Asensus Surgical, Inc. (NYSE American: ASXC), Asensus Surgical, a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, announced today that it will be presenting at the 15th annual Main Event on Tuesday, October 25th at 8:30 AM PT at the Luxe Sunset Boulevard Hotel.

Asensus Surgical, Inc. To Present at The LD Micro Main Event XV

System to be Utilized by the Oncology-Focused Clinic for General and Visceral Surgery System to be Utilized by the Oncology-Focused Clinic for General and Visceral Surgery

Asensus Surgical Announces St. Bernhard Hospital in Germany to Initiate Senhance Surgery Program

RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Saiseikai Shiga Hospital in Ritto, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System.

Asensus Surgical Announces Saiseikai Shiga Hospital in Japan to Initiate Senhance Surgery Program

Semler Scientific

Shockwave Medical

The Zacks Medical - Instruments industry is growing on R&D investments. SWAV, SMLR and ASXC are set to gain the most.

3 Medical Instruments Stocks to Buy Despite Industry Headwinds

RESEARCH TRIANGLE PARK, N.C., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the H. C. Wainwright 24th Annual Global Investment Conference in New York City, New York. The Company's fireside chat will take place on Monday, September 12, 2022 at 9:30 AM Eastern Time.

Asensus Surgical to Participate in the H. C. Wainwright Global Investment Conference

Asensus Surgical, Inc. (NYSE:ASXC ) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Mark Klausner - Investor Relations Anthony Fernando - President and Chief Executive Officer Shameze Rampertab - Chief Financial Officer Conference Call Participants RK Ramakanth - H.C. Wainwright Ross Osborn - Cantor Fitzgerald Operator Thank you for standing by.

News for Asensus Surgical Stock (ASXC)